The novel tellurium immunomodulator AS101 inhibits interleukin-10 production and p38 MAPK expression in atopic dermatitis
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-06-01
著者
-
Chan Chi-chao
National Institutes Of Health Laboratory Of Immunology National Eye Institute
-
SREDNI-KENIGSBUCH Dvora
Interdisciplinary Department, Bar-Ilan University
-
SHOHAT Michael
Department of Dermatology, Schneider Children's Hospital, Rabin Medical Center
-
SHOHAT Batia
Cellular Immunology Unit, Schneider Children's Hospital, Rabin Medical Center
-
BEN-AMITAI Dan
Pediatric-Dermatology Unit, Schneider Children's Hospital, Rabin Medical Center
-
DAVID Michael
Department of Dermatology, Schneider Children's Hospital, Rabin Medical Center
-
Shohat Batia
Cellular Immunology Unit Schneider Children's Hospital Rabin Medical Center
-
David Michael
Department Of Dermatology Schneider Children's Hospital Rabin Medical Center
-
Shohat Michael
Department Of Dermatology Schneider Children's Hospital Rabin Medical Center
-
Ben-amitai Dan
Pediatric-dermatology Unit Schneider Children's Hospital Rabin Medical Center
-
Sredni-kenigsbuch Dvora
Interdisciplinary Department Bar-ilan University